SCHEMBL7551901

SCHEMBL7551901

CC(CN(C)C)n1cc(-c2cncc(-c3ccccc3)c2)c2ncccc21

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDR P35968 3/20 0.42
FLT1 P17948 1/20 0.42
FLT4 P35916 1/20 0.42
GRIN2B Q13224 4/20 0.33
HTR6 P50406 1/20 0.33
BRD9 Q9H8M2 2/20 0.32
BRD7 Q9NPI1 2/20 0.32
PDE4A P27815 1/20 0.32
PDE10A Q9Y233 1/20 0.32
KAT2B Q92831 1/20 0.31
MAOB P27338 1/20 0.31
TSHR P16473 2/20 0.31
BRD4 O60885 2/20 0.31
CYP3A4 P08684 4/20 0.31
KDM4E B2RXH2 2/20 0.31
ALDH1A1 P00352 2/20 0.31
HSD17B10 Q99714 2/20 0.31
CYP2E1 P05181 2/20 0.31
CYP2A6 P11509 2/20 0.31
CYP2C9 P11712 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7549779 0.84 KDR (0.54) KDRFLT1FLT4
SCHEMBL7986720 0.83 KDR (0.59) KDRFLT1FLT4GRIN2BHTR6
SCHEMBL7548486 0.80 KDR (0.41) KDRFLT1FLT4GRIN2B
SCHEMBL7557902 0.78 KDR (0.46) KDRFLT1FLT4HTR6
SCHEMBL7548512 0.78 KDR (0.43) KDRFLT1FLT4HTR6KDM4E
SCHEMBL7552885 0.77 KDR (0.51) KDRFLT1FLT4HTR6
SCHEMBL7548397 0.77 KDR (0.57) KDRFLT1FLT4HTR6CYP2D6
SCHEMBL7555466 0.76 PDE4B (0.46) KDRFLT1FLT4HTR6TSHR
SCHEMBL7549609 0.75 KDR (0.49) KDRFLT1FLT4GRIN2B
SCHEMBL7550587 0.75 KDR (0.49) KDRFLT1FLT4HTR6CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1147107-A4 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO INC (US) 2002-05-22 EP claimed
EP-1147107-A1 NOVEL ANGIOGENESIS INHIBITORS Merck & Co., Inc. (US) 2001-10-24 EP claimed
WO-2000043393-A1 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO., INC. (US) 2000-07-27 WO claimed
EP-1147107-A4 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO INC (US) 2002-05-22 EP disclosed
EP-1147107-A1 NOVEL ANGIOGENESIS INHIBITORS Merck & Co., Inc. (US) 2001-10-24 EP disclosed
US-6265403-B1 TYROSINE INHIBITORS MERCK & CO., INC. 2001-07-24 US disclosed
WO-2000043393-A1 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO., INC. (US) 2000-07-27 WO disclosed